Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine

PURPOSE: The combination of platinum compounds and vinorelbine is often used as a first-line treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), without activating EGFR mutations and ALK rearrangement. Unfortunately, less than half of the patients benefit fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlak, Radosław, Krawczyk, Paweł, Ciesielka, Marzanna, Homa, Iwona, Powrózek, Tomasz, Prendecka, Monika, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540763/
https://www.ncbi.nlm.nih.gov/pubmed/26220844
http://dx.doi.org/10.1007/s00280-015-2831-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540763/
https://www.ncbi.nlm.nih.gov/pubmed/26220844
http://dx.doi.org/10.1007/s00280-015-2831-7

Ejemplares similares